Evolution of the Average Target: Northwest Biotherapeutics, Inc.

Evolution of the Target Price: Northwest Biotherapeutics, Inc.

Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.

9876353d54.aW0rZi1woSnX8foelH2Dtkthkrm8e9qxXOrdQ27mul0.XiB5AUwJ72q0vKVNxjD0hjID_MPvLKzGLpDsJBvU3BEeXBoxaROTQ--Iow~3bee7c67d2eceeb76c5cffaa067c0dd5

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.62%
+22.39%
+9.04%
+69.15%
+18.27%
+6.59%
+20.98%
-8.02%
+36.13%
Average +21.13%
Weighted average by Cap. +21.07%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1525USD
Average target price
1.000USD
Spread / Average Target
+555.74%
High Price Target
1.000USD
Spread / Highest target
+555.74%
Low Price Target
1.000USD
Spread / Lowest Target
+555.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. NWBO Stock
  4. NBYB Stock
  5. Consensus Northwest Biotherapeutics, Inc.